Dutch medtech company CC Diagnostics has won the MedTech Twente NextGen Award 2026, receiving a €10,000 prize for its innovation aimed at improving cervical cancer detection.
The award was presented on 5 November at the TechMed Event, where four start-ups pitched their innovations to a jury. CC Diagnostics was represented by Ilinka Stanciu, who presented the company’s approach to detecting cervical cancer at an earlier stage, potentially before the disease develops.
The jury selected the winner from four finalists.
The MedTech Twente NextGen Award shines a spotlight on promising MedTech startups, giving them the opportunity to showcase their innovations, expand their network, and accelerate their growth journey.
The Award is a new program for MedTech startups in the Netherlands and North Rhine-Westphalia. The program is aimed at startups with a prototype or validated concept and provides support in taking the next step toward market entry and implementation within healthcare. In addition to gaining access to experts and a relevant network, participants have the opportunity to compete for a €10,000 grand prize.
